At Washington Biotech we are continuously expanding, improving and upgrading our in vivo and in vitro services. This is what drives our scientists and this is what our clients count on. And it is this continuous commitment to innovation that sets us apart as the Preclinical CRO "Partner of Choice".
We keep our valued clients and the biomedical research community in general apprised of our latest developments through our E-Newsletter.
We know the importance of timely value. For this reason we issue our Newsletter in "real-time", i.e. as soon as new or modified services are brought online.
If you would like to receive the most up-to-date information on our services, please join our mailing list. The information you receive may be important for your next study.
For your information, here is a Quick View of some archived Newsletters. Thank you for your interest.